Literature DB >> 10542823

Psychosocial consequences of age-related visual impairment: comparison with mobility-impaired older adults and long-term outcome.

H W Wahl1, O Schilling, F Oswald, V Heyl.   

Abstract

Indices of behavioral competence (activities of daily living [ADLs], instrumental activities of daily living [IADLs], use of outdoor resources, leisure activity level) as well as emotional adaptation (subjective well-being, future orientation) were used to investigate the psychosocial consequences of age-related vision impairment in a threefold manner: (a) comparison of visually impaired and unimpaired elders, (b) comparison of visually impaired and mobility-impaired elders, and (c) long-term adaptation across 5 years. The research design used (a) 42 severely visually impaired elders, (b) 42 blind elders, (c) 42 mobility-impaired elders, and (d) 42 unimpaired elders. Compared with the mobility impaired, the visually impaired demonstrated lower IADL competence but no difference in emotional adaptation. The long-term adjustment of the visually impaired remained relatively stable in the behavioral domain, although lower compared with the unimpaired elders. Emotional adaptation decreased over the 5-year longitudinal interval in the visually impaired and the unimpaired group, but the decrease was generally higher in the visually impaired group. Conceptual ideas from environmental gerontology as well as psychological resilience are used to interpret these results.

Entities:  

Mesh:

Year:  1999        PMID: 10542823     DOI: 10.1093/geronb/54b.5.p304

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  13 in total

1.  [A psychosocial training program for elderly patients with age-related macular degeneration: findings of a pilot evaluation study].

Authors:  T Birk; S Hickl; H-W Wahl; A Kämmerer; D Miller; F Holz; S Becker
Journal:  Z Gerontol Geriatr       Date:  2004-10       Impact factor: 1.281

2.  [Quality of life by limited vision in old age: the example of age-related macula degeneration].

Authors:  H-W Wahl; V Heyl; N Langer
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

3.  The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.

Authors:  Silvia Sörensen; Katherine White; Wingyun Mak; Katherine Zanibbi; Wan Tang; Amanda O'Hearn; Mark T Hegel
Journal:  Contemp Clin Trials       Date:  2015-03-24       Impact factor: 2.226

4.  Poor vision, functioning, and depressive symptoms: a test of the activity restriction model.

Authors:  Jamila Bookwala; Brendan Lawson
Journal:  Gerontologist       Date:  2011-07-06

5.  Does Visual Impairment Affect Social Ties in Late Life? Findings of a Multicenter Prospective Cohort Study in Germany.

Authors:  A Hajek; C Brettschneider; D Lühmann; M Eisele; S Mamone; B Wiese; S Weyerer; J Werle; M Pentzek; A Fuchs; J Stein; T Luck; H Bickel; D Weeg; K Heser; F Jessen; W Maier; M Scherer; S G Riedel-Heller; H-H König
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

6.  Aging and the perception of egocentric distance.

Authors:  Zheng Bian; George J Andersen
Journal:  Psychol Aging       Date:  2012-12-31

7.  Marital quality as a moderator of the effects of poor vision on quality of life among older adults.

Authors:  Jamila Bookwala
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-09       Impact factor: 4.077

Review 8.  Aging and vision: changes in function and performance from optics to perception.

Authors:  George J Andersen
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2012-02-16

9.  [Systemic diagnostic error of senile dementia by cataract-related impairment of information processing?].

Authors:  S Lehrl; K Gerstmeyer
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

10.  [Cataract-related changes of intelligence. An innovative aspect].

Authors:  K Gerstmeyer; S Lehrl
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.